245 related articles for article (PubMed ID: 23704898)
1. Comparison of internal ribosome entry site (IRES) and Furin-2A (F2A) for monoclonal antibody expression level and quality in CHO cells.
Ho SC; Bardor M; Li B; Lee JJ; Song Z; Tong YW; Goh LT; Yang Y
PLoS One; 2013; 8(5):e63247. PubMed ID: 23704898
[TBL] [Abstract][Full Text] [Related]
2. Impact of Signal Peptides on Furin-2A Mediated Monoclonal Antibody Secretion in CHO Cells.
Lin J; Neo SH; Ho SCL; Yeo JHM; Wang T; Zhang W; Bi X; Chao SH; Yang Y
Biotechnol J; 2017 Sep; 12(9):. PubMed ID: 28727292
[TBL] [Abstract][Full Text] [Related]
3. Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.
Chng J; Wang T; Nian R; Lau A; Hoi KM; Ho SC; Gagnon P; Bi X; Yang Y
MAbs; 2015; 7(2):403-12. PubMed ID: 25621616
[TBL] [Abstract][Full Text] [Related]
4. Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability.
Ho SC; Koh EY; van Beers M; Mueller M; Wan C; Teo G; Song Z; Tong YW; Bardor M; Yang Y
J Biotechnol; 2013 Jun; 165(3-4):157-66. PubMed ID: 23583871
[TBL] [Abstract][Full Text] [Related]
5. An IRES-Mediated Tricistronic Vector for Efficient Generation of Stable, High-Level Monoclonal Antibody Producing CHO DG44 Cell Lines.
Yeo JHM; Mariati ; Yang Y
Methods Mol Biol; 2018; 1827():335-349. PubMed ID: 30196505
[TBL] [Abstract][Full Text] [Related]
6. IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines.
Ho SC; Bardor M; Feng H; Mariati ; Tong YW; Song Z; Yap MG; Yang Y
J Biotechnol; 2012 Jan; 157(1):130-9. PubMed ID: 22024589
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells.
Ebadat S; Ahmadi S; Ahmadi M; Nematpour F; Barkhordari F; Mahdian R; Davami F; Mahboudi F
PLoS One; 2017; 12(10):e0185967. PubMed ID: 29023479
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of different IRES-mediated tricistronic plasmid designs for expression of an anti-PCSK9 biosimilar monoclonal antibody in CHO cells.
Cruz TA; Pinho MB; Castilho LR
Biotechnol Lett; 2020 Dec; 42(12):2511-2522. PubMed ID: 32676798
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies.
Li J; Menzel C; Meier D; Zhang C; Dübel S; Jostock T
J Immunol Methods; 2007 Jan; 318(1-2):113-24. PubMed ID: 17161420
[TBL] [Abstract][Full Text] [Related]
10. On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells.
Schlatter S; Stansfield SH; Dinnis DM; Racher AJ; Birch JR; James DC
Biotechnol Prog; 2005; 21(1):122-33. PubMed ID: 15903249
[TBL] [Abstract][Full Text] [Related]
11. IgG Aggregation Mechanism for CHO Cell Lines Expressing Excess Heavy Chains.
Ho SC; Wang T; Song Z; Yang Y
Mol Biotechnol; 2015 Jul; 57(7):625-34. PubMed ID: 25744439
[TBL] [Abstract][Full Text] [Related]
12. Construction strategies for developing expression vectors for recombinant monoclonal antibody production in CHO cells.
Li YM; Tian ZW; Xu DH; Wang XY; Wang TY
Mol Biol Rep; 2018 Dec; 45(6):2907-2912. PubMed ID: 30191354
[TBL] [Abstract][Full Text] [Related]
13. Optimized Selection Marker and CHO Host Cell Combinations for Generating High Monoclonal Antibody Producing Cell Lines.
Yeo JHM; Ho SCL; Mariati M; Koh E; Tay SJ; Woen S; Zhang P; Yang Y
Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 29090854
[TBL] [Abstract][Full Text] [Related]
14. Analysis of monoclonal antibody product heterogeneity resulting from alternate cleavage sites of signal peptide.
Kotia RB; Raghani AR
Anal Biochem; 2010 Apr; 399(2):190-5. PubMed ID: 20074542
[TBL] [Abstract][Full Text] [Related]
15. Optimization of heavy chain and light chain signal peptides for high level expression of therapeutic antibodies in CHO cells.
Haryadi R; Ho S; Kok YJ; Pu HX; Zheng L; Pereira NA; Li B; Bi X; Goh LT; Yang Y; Song Z
PLoS One; 2015; 10(2):e0116878. PubMed ID: 25706993
[TBL] [Abstract][Full Text] [Related]
16. Analysis of IgG heavy chain to light chain ratio with mutant Encephalomyocarditis virus internal ribosome entry site.
Li J; Zhang C; Jostock T; Dübel S
Protein Eng Des Sel; 2007 Oct; 20(10):491-6. PubMed ID: 17951613
[TBL] [Abstract][Full Text] [Related]
17. An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo.
Fang J; Yi S; Simmons A; Tu GH; Nguyen M; Harding TC; VanRoey M; Jooss K
Mol Ther; 2007 Jun; 15(6):1153-9. PubMed ID: 17375065
[TBL] [Abstract][Full Text] [Related]
18. Antibody engineering to improve manufacturability.
Wijesuriya SD; Pongo E; Tomic M; Zhang F; Garcia-Rodriquez C; Conrad F; Farr-Jones S; Marks JD; Horwitz AH
Protein Expr Purif; 2018 Sep; 149():75-83. PubMed ID: 29655788
[TBL] [Abstract][Full Text] [Related]
19. Impact of gene vector design on the control of recombinant monoclonal antibody production by Chinese hamster ovary cells.
Davies SL; O'Callaghan PM; McLeod J; Pybus LP; Sung YH; Rance J; Wilkinson SJ; Racher AJ; Young RJ; James DC
Biotechnol Prog; 2011; 27(6):1689-99. PubMed ID: 21882365
[TBL] [Abstract][Full Text] [Related]
20. Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity.
Shen Y; Zeng L; Zhu A; Blanc T; Patel D; Pennello A; Bari A; Ng S; Persaud K; Kang YK; Balderes P; Surguladze D; Hindi S; Zhou Q; Ludwig DL; Snavely M
MAbs; 2013; 5(3):418-31. PubMed ID: 23567210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
